Mini Review

Published on 02 Jun 2021

Clinical Trials Supporting the Role of the IL-17/IL-23 Axis in Axial Spondyloarthritis

in Cytokines and Soluble Mediators in Immunity

Angela Ceribelli
Francesca Motta
Matteo Vecellio
Natasa Isailovic
Francesco Ciccia
Carlo Selmi

Frontiers in Immunology

doi 10.3389/fimmu.2021.622770

11,452 views
22 citations

Review

Published on 01 Jun 2021

Inflammatory Pathophysiology as a Contributor to Myeloproliferative Neoplasms

in Cytokines and Soluble Mediators in Immunity

Daniel Arthur Corpuz Fisher
Jared Scott Fowles
Amy Zhou
Stephen Tracy Oh

Frontiers in Immunology

doi 10.3389/fimmu.2021.683401

17,358 views
75 citations

Review

Published on 27 May 2021

Autoantibody Discovery, Assay Development and Adoption: Death Valley, the Sea of Survival and Beyond

in Cytokines and Soluble Mediators in Immunity

Marvin J. Fritzler
May Y. Choi
Minoru Satoh
Michael Mahler

Frontiers in Immunology

doi 10.3389/fimmu.2021.679613

7,098 views
15 citations

Review

Published on 24 May 2021

Adipose Extracellular Vesicles: Messengers From and to Macrophages in Regulating Immunometabolic Homeostasis or Disorders

in Cytokines and Soluble Mediators in Immunity

Zixin Zhou
Yan Tao
Hui Zhao
Qun Wang

Frontiers in Immunology

doi 10.3389/fimmu.2021.666344

6,888 views
20 citations

Original Research

Published on 21 May 2021

IL-10−/− Enhances DCs Immunity Against Chlamydia psittaci Infection via OX40L/NLRP3 and IDO/Treg Pathways

in Cytokines and Soluble Mediators in Immunity

Qiang Li
Xiaohui Li
Hongkun Quan
Yihui Wang
Guanggang Qu
Zhiqiang Shen
Cheng He

Frontiers in Immunology

doi 10.3389/fimmu.2021.645653

4,652 views
11 citations

Editorial

Published on 19 May 2021

Editorial: Purinergic Signaling and Inflammation

in Cytokines and Soluble Mediators in Immunity

Xiaoyi Yuan
Davide Ferrari
Tingting Mills
Yanyu Wang
Agnieszka Czopik
Marie-Francoise Doursout
Scott E. Evans
Marco Idzko
Holger K. Eltzschig

Frontiers in Immunology

doi 10.3389/fimmu.2021.699069

3,817 views
7 citations

Perspective

Published on 18 May 2021

Novel Anti-Cytokine Strategies for Prevention and Treatment of Respiratory Allergic Diseases

in Cytokines and Soluble Mediators in Immunity

Ekaterina O. Gubernatorova
Olga A. Namakanova
Ekaterina. A. Gorshkova
Alexandra D. Medvedovskaya
Sergei A. Nedospasov
Marina S. Drutskaya

Frontiers in Immunology

doi 10.3389/fimmu.2021.601842

8,247 views
23 citations

Review

Published on 17 May 2021

Future Biomarkers for Infection and Inflammation in Febrile Children

in Cytokines and Soluble Mediators in Immunity

Judith Zandstra
Ilse Jongerius
Taco W. Kuijpers

Frontiers in Immunology

doi 10.3389/fimmu.2021.631308

12,053 views
14 citations

Mini Review

Published on 17 May 2021

The IL23-IL17 Immune Axis in the Treatment of Ulcerative Colitis: Successes, Defeats, and Ongoing Challenges

in Cytokines and Soluble Mediators in Immunity

Daniele Noviello
Riccardo Mager
Giulia Roda
Riccardo G. Borroni
Gionata Fiorino
Stefania Vetrano

Frontiers in Immunology

doi 10.3389/fimmu.2021.611256

23,572 views
71 citations

Editorial

Published on 14 May 2021

Editorial: Cytokines and Intestinal Mucosal Immunity

in Cytokines and Soluble Mediators in Immunity

Theresa T. Pizarro
Charles A. Dinarello
Fabio Cominelli

Frontiers in Immunology

doi 10.3389/fimmu.2021.698693

4,046 views
3 citations

Review

Published on 14 May 2021

Autoantibodies in Rheumatoid Arthritis – Laboratory and Clinical Perspectives

in Cytokines and Soluble Mediators in Immunity

Johan Rönnelid
Carl Turesson
Alf Kastbom

Frontiers in Immunology

doi 10.3389/fimmu.2021.685312

22,466 views
62 citations

Original Research

Published on 14 May 2021

Serum Interleukin-26 Is a New Biomarker for Disease Activity Assessment in Systemic Lupus Erythematosus

in Cytokines and Soluble Mediators in Immunity

Benoit Brilland
Maxime Bach-Bunner
Christopher Nunes Gomes
Vincent Larochette
Etienne Foucher
Marc Plaisance
Patrick Saulnier
Nathalie Costedoat-Chalumeau
Pascale Ghillani
Cristina Belizna

Frontiers in Immunology

doi 10.3389/fimmu.2021.663192

4,018 views
11 citations

Original Research

Published on 13 May 2021

Gender May Influence the Immunosuppressive Actions of Prednisone in Young Patients With Inflammatory Bowel Disease

in Cytokines and Soluble Mediators in Immunity

Marianna Lucafò
Matteo Bramuzzo
Davide Selvestrel
Prisca Da Lozzo
Giuliana Decorti
Gabriele Stocco

Frontiers in Immunology

doi 10.3389/fimmu.2021.673068

2,675 views
6 citations

Original Research

Published on 13 May 2021

Chemokines in Prediabetes and Type 2 Diabetes: A Meta-Analysis

in Cytokines and Soluble Mediators in Immunity

Xiongfeng Pan
Atipatsa C. Kaminga
Shi Wu Wen
Aizhong Liu

Frontiers in Immunology

doi 10.3389/fimmu.2021.622438

7,341 views
52 citations

Editorial

Published on 12 May 2021

Editorial: Quo Vadis Lipid Mediators – Lipid Mediators Implication in Inflammation and Chronic Inflammatory Diseases

in Cytokines and Soluble Mediators in Immunity

Danuta Radzioch
Martin Giera
Juan Bautista De Sanctis

Frontiers in Immunology

doi 10.3389/fimmu.2021.699276

1,617 views
1 citation

Original Research

Published on 11 May 2021

Glucocorticoid-Induced Exacerbation of Mycobacterial Infection Is Associated With a Reduced Phagocytic Capacity of Macrophages

in Cytokines and Soluble Mediators in Immunity

Yufei Xie
Jiajun Xie
Annemarie H. Meijer
Marcel J. M. Schaaf

Frontiers in Immunology

doi 10.3389/fimmu.2021.618569

4,210 views
16 citations

Navigation group

Articles

Clinical Trials Supporting the Role of the IL-17/IL-23 Axis in Axial Spondyloarthritis

Inflammatory Pathophysiology as a Contributor to Myeloproliferative Neoplasms

Autoantibody Discovery, Assay Development and Adoption: Death Valley, the Sea of Survival and Beyond

Adipose Extracellular Vesicles: Messengers From and to Macrophages in Regulating Immunometabolic Homeostasis or Disorders

IL-10−/− Enhances DCs Immunity Against Chlamydia psittaci Infection via OX40L/NLRP3 and IDO/Treg Pathways

Editorial: Purinergic Signaling and Inflammation

Novel Anti-Cytokine Strategies for Prevention and Treatment of Respiratory Allergic Diseases

Future Biomarkers for Infection and Inflammation in Febrile Children

The IL23-IL17 Immune Axis in the Treatment of Ulcerative Colitis: Successes, Defeats, and Ongoing Challenges

Editorial: Cytokines and Intestinal Mucosal Immunity

Autoantibodies in Rheumatoid Arthritis – Laboratory and Clinical Perspectives

Serum Interleukin-26 Is a New Biomarker for Disease Activity Assessment in Systemic Lupus Erythematosus

Gender May Influence the Immunosuppressive Actions of Prednisone in Young Patients With Inflammatory Bowel Disease

Chemokines in Prediabetes and Type 2 Diabetes: A Meta-Analysis

Editorial: Quo Vadis Lipid Mediators – Lipid Mediators Implication in Inflammation and Chronic Inflammatory Diseases

Glucocorticoid-Induced Exacerbation of Mycobacterial Infection Is Associated With a Reduced Phagocytic Capacity of Macrophages